| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.31e-14 | 114 | 201 | 16 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.28e-13 | 124 | 201 | 16 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.20e-13 | 137 | 201 | 16 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.11e-10 | 192 | 201 | 16 | GO:0008234 |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 REPS1 CDHR1 CDH23 ACTN4 ACTN3 ADGRV1 FAT1 OTOF ACAN PCLO PCDH11Y SCUBE2 CELSR3 CELSR2 DCHS1 UNC13C RAPGEF2 CDH1 PCDH7 CDH17 TPD52 | 7.12e-06 | 749 | 201 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ERC1 SPTBN1 CDH23 S1PR2 ACTN4 ACTN3 AFDN CNTN1 FLNB FN1 ANK3 NRCAM TNN TLN1 DCHS1 CDH1 PLIN3 CDH17 ZC3HAV1 | 1.07e-05 | 599 | 201 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR HAUS6 MAP1A SPTBN1 ACTN4 ACTN3 ADGRV1 CEP350 ALMS1 AFDN FLNB TRIM2 ANK2 ANK3 NRCAM ARPC1A ARFGEF1 RHO LRPPRC TIAM1 MICAL2 TLN1 LIMCH1 TRAK2 CDH1 | 1.18e-04 | 1099 | 201 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | cadherin binding | ERC1 SPTBN1 CDH23 AFDN FLNB ANK3 TLN1 DCHS1 CDH1 PLIN3 CDH17 ZC3HAV1 | 1.75e-04 | 339 | 201 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 KLK4 USP17L6P USP17L22 USP17L15 | 3.48e-04 | 654 | 201 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.27e-04 | 42 | 201 | 4 | GO:0098918 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.23e-14 | 125 | 200 | 16 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 7.74e-13 | 144 | 200 | 16 | GO:0070646 |
| GeneOntologyBiologicalProcess | retina homeostasis | 1.89e-07 | 64 | 200 | 8 | GO:0001895 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDHR1 CDH23 FAT1 NRCAM PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.01e-07 | 187 | 200 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 3.29e-07 | 47 | 200 | 7 | GO:0045494 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAP1A CDHR1 CDH23 LAMC3 TTC3 TIAM2 KIAA0319 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 CELSR2 TIAM1 TNN MAP3K13 TRAK2 RAPGEF2 CDH1 | 1.08e-06 | 748 | 200 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDHR1 CDH23 MDGA2 WNK1 FAT1 NRCAM PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 2.41e-06 | 313 | 200 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuron development | MAP1A CDHR1 CDH23 LAMC3 ADGRV1 TTC3 WNK1 TIAM2 KIAA0319 ALMS1 AP5Z1 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ARFGEF1 GPRIN3 ALS2 ZMIZ1 CELSR3 CELSR2 TIAM1 TNN CSPG4 MAP3K13 TRAK2 RAPGEF2 CDH1 VPS13B GPRC5B | 4.63e-06 | 1463 | 200 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | MAP1A CDH23 LAMC3 ADGRV1 TTC3 TIAM2 KIAA0319 ALMS1 AP5Z1 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ARFGEF1 GPRIN3 ALS2 CELSR3 CELSR2 TIAM1 TNN CSPG4 MAP3K13 TRAK2 RAPGEF2 CDH1 VPS13B GPRC5B | 6.84e-06 | 1285 | 200 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | axonogenesis | MAP1A LAMC3 TTC3 TIAM2 KIAA0319 CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 TIAM1 TNN MAP3K13 TRAK2 CDH1 | 1.09e-05 | 566 | 200 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis | METTL3 MAP1A CDHR1 CDH23 LAMC3 TTC3 TIAM2 KIAA0319 FAT1 AFDN CNTN1 FLNB ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 PRPF40A CELSR3 CELSR2 TIAM1 TNN MAP3K13 TRAK2 RAPGEF2 CDH1 CDH17 | 1.32e-05 | 1194 | 200 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | axon development | MAP1A LAMC3 TTC3 TIAM2 KIAA0319 AP5Z1 CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 TIAM1 TNN MAP3K13 TRAK2 CDH1 | 1.68e-05 | 642 | 200 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell junction organization | ERC1 S1PR2 MDGA2 ACTN4 ACTN3 AFDN CACNB3 FN1 ANK2 ANK3 LRRN1 NRCAM KALRN PCLO ALS2 ARHGAP6 INA TIAM1 SETD5 TLN1 LIMCH1 RAPGEF2 CDH1 CDH17 | 2.65e-05 | 974 | 200 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MAP1A LAMC3 TTC3 TIAM2 KIAA0319 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 CELSR2 TIAM1 TNN MAP3K13 TRAK2 RAPGEF2 CDH1 | 3.66e-05 | 802 | 200 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell junction assembly | S1PR2 MDGA2 ACTN4 ACTN3 AFDN FN1 ANK2 LRRN1 NRCAM PCLO ARHGAP6 SETD5 TLN1 LIMCH1 RAPGEF2 CDH1 CDH17 | 4.22e-05 | 569 | 200 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L20 USP17L19 TTC3 WNK1 BIRC6 USP20 USP17L18 FBXO4 USP17L17 USP15 USP17L13 TRIM2 USP17L12 USP17L11 USP17L24 USP17L5 PELI2 USP17L10 ZMIZ1 USP17L6P SYVN1 USP17L22 USP17L15 ZC3HAV1 | 4.53e-05 | 1074 | 200 | 25 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L20 USP17L19 TTC3 WNK1 BIRC6 USP20 USP17L18 FBXO4 USP17L17 USP15 USP17L13 TRIM2 USP17L12 USP17L11 USP17L24 USP17L5 PELI2 USP17L10 ZMIZ1 USP17L6P SYVN1 USP17L22 USP17L15 | 4.64e-05 | 1009 | 200 | 24 | GO:0070647 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MAP1A LAMC3 TTC3 TIAM2 KIAA0319 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 CELSR2 TIAM1 TNN MAP3K13 TRAK2 RAPGEF2 CDH1 | 4.95e-05 | 819 | 200 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MAP1A LAMC3 TTC3 TIAM2 KIAA0319 AFDN CNTN1 ARHGEF28 FN1 ANK3 NRCAM KALRN ALS2 CELSR3 CELSR2 TIAM1 TNN MAP3K13 TRAK2 RAPGEF2 CDH1 | 5.59e-05 | 826 | 200 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.96e-04 | 207 | 200 | 9 | GO:1990138 | |
| GeneOntologyBiologicalProcess | neuron migration | 2.88e-04 | 218 | 200 | 9 | GO:0001764 | |
| GeneOntologyBiologicalProcess | endosomal transport | REPS1 ERC1 ALMS1 AP5Z1 TBC1D14 ALS2 EPG5 PIKFYVE LRBA VPS13B SORL1 | 3.05e-04 | 320 | 200 | 11 | GO:0016197 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TTC3 TIAM2 KIAA0319 AFDN CNTN1 FN1 NRCAM KALRN TIAM1 TNN CSPG4 MAP3K13 TRAK2 RAPGEF2 CDH1 GPRC5B | 3.25e-04 | 612 | 200 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 METTL3 CDHR1 CDH23 MDGA2 ADGRV1 WNK1 FAT1 AFDN IL23R CNTN1 SELPLG ANK3 NRCAM PCDH11Y ZMIZ1 CELSR3 CELSR2 TLN1 DCHS1 CDH1 PCDH7 CDH17 | 3.25e-04 | 1077 | 200 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | SPTBN1 WNK1 TTC7B AFDN CACNB3 ANK2 ANK3 DCHS1 RAPGEF2 CDH1 SORL1 | 3.39e-04 | 324 | 200 | 11 | GO:0072659 |
| GeneOntologyCellularComponent | main axon | 2.22e-06 | 89 | 200 | 8 | GO:0044304 | |
| GeneOntologyCellularComponent | postsynaptic density | DLGAP1 MAP1A ERC1 SPTBN1 AFDN ANK2 ANK3 NRCAM KALRN PCLO GRIA3 ALS2 INA CELSR3 TIAM1 PCBP2 | 7.59e-06 | 451 | 200 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | DLGAP1 MAP1A ERC1 SPTBN1 AFDN ANK2 ANK3 NRCAM KALRN PCLO GRIA3 ALS2 INA CELSR3 TIAM1 PCBP2 | 1.52e-05 | 477 | 200 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | DLGAP1 MAP1A ERC1 SPTBN1 AFDN ANK2 ANK3 NRCAM KALRN PCLO GRIA3 ALS2 INA CELSR3 TIAM1 PCBP2 | 2.90e-05 | 503 | 200 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | glutamatergic synapse | DLGAP1 ERC1 SPTBN1 S1PR2 MDGA2 ACAN SIPA1L2 CNTN1 NRCAM KALRN PCLO ARPC1A GRIA3 ALS2 SLC1A2 INA CELSR3 TIAM1 CDH1 GABBR1 TPD52 | 3.95e-05 | 817 | 200 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | neuron to neuron synapse | DLGAP1 MAP1A ERC1 SPTBN1 AFDN ANK2 ANK3 NRCAM KALRN PCLO GRIA3 ALS2 INA CELSR3 TIAM1 PCBP2 | 4.62e-05 | 523 | 200 | 16 | GO:0098984 |
| GeneOntologyCellularComponent | cell projection membrane | CDHR1 SLC26A4 SPTBN1 ADGRV1 SLC39A6 ARPC1A SLC1A2 RHO TIAM1 TLN1 CSPG4 MTTP SLC5A8 GABBR1 | 7.39e-05 | 431 | 200 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | postsynapse | DLGAP1 MAP1A ERC1 SPTBN1 S1PR2 ACTN4 AFDN CNTN1 ANK2 ANK3 NRCAM KALRN PCLO GRIA3 ALS2 SLC1A2 INA CELSR3 TIAM1 RAPGEF2 PCBP2 CDH1 GABBR1 | 1.19e-04 | 1018 | 200 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | catenin complex | 2.37e-04 | 32 | 200 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.08e-04 | 223 | 200 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.56e-04 | 137 | 200 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | presynaptic active zone | 4.24e-04 | 141 | 200 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | apical part of cell | SLC26A4 CDH23 HAVCR1 FAT1 OTOF SLC39A6 AFDN CACNB3 FN1 ANK2 CSPG4 DCHS1 SLC5A8 RAPGEF2 CDH1 | 6.02e-04 | 592 | 200 | 15 | GO:0045177 |
| GeneOntologyCellularComponent | non-motile cilium | 6.16e-04 | 196 | 200 | 8 | GO:0097730 | |
| GeneOntologyCellularComponent | node of Ranvier | 8.72e-04 | 20 | 200 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | leading edge membrane | 9.66e-04 | 210 | 200 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | axolemma | 1.01e-03 | 21 | 200 | 3 | GO:0030673 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.33e-03 | 23 | 200 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 1.33e-03 | 6 | 200 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.44e-03 | 277 | 200 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | DLGAP1 ERC1 OTOF AFDN CNTN1 ANK2 ANK3 NRCAM GRIA3 SLC1A2 CELSR3 TIAM1 UNC13C GABBR1 | 1.52e-03 | 583 | 200 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.53e-03 | 129 | 200 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.72e-03 | 230 | 200 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 OTOF SUCO USP17L13 USP17L12 USP17L11 PIGS POR USP17L5 USP17L10 RHO LRPPRC THADA USP17L6P LRBA SYVN1 USP17L22 USP17L15 GABBR1 SORL1 | 2.02e-03 | 1327 | 200 | 24 | GO:0042175 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.23e-03 | 139 | 200 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.46e-03 | 8 | 200 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | axon initial segment | 2.62e-03 | 29 | 200 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.83e-03 | 306 | 200 | 9 | GO:0005802 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 OTOF SUCO USP17L13 USP17L12 USP17L11 PIGS POR USP17L5 USP17L10 RHO THADA USP17L6P LRBA SYVN1 USP17L22 USP17L15 GABBR1 SORL1 | 3.08e-03 | 1293 | 200 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | centrosome | HAUS6 ERC1 CDH23 CNTLN BIRC6 USP20 CEP350 CEP120 ALMS1 WRN E2F1 ALS2 CEP192 CCDC141 TIAM1 CKAP2L | 3.09e-03 | 770 | 200 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 3.14e-03 | 9 | 200 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 3.14e-03 | 9 | 200 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | microtubule organizing center | SPATA7 HAUS6 ERC1 CDH23 CNTLN BIRC6 USP20 CEP350 CEP120 ALMS1 WRN E2F1 ALS2 CEP192 CCDC141 TIAM1 WDR11 CKAP2L | 3.25e-03 | 919 | 200 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 OTOF SUCO USP17L13 USP17L12 USP17L11 PIGS POR USP17L5 USP17L10 RHO THADA USP17L6P LRBA SYVN1 USP17L22 USP17L15 GABBR1 SORL1 | 3.26e-03 | 1299 | 200 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | cell leading edge | SPTBN1 ADGRV1 TIAM2 FAT1 SLC39A6 ALS2 SLC1A2 TIAM1 TLN1 CSPG4 CDH1 GABBR1 | 3.27e-03 | 500 | 200 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | brush border | 3.48e-03 | 152 | 200 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | ribbon synapse | 3.49e-03 | 32 | 200 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 3.59e-03 | 153 | 200 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 4.31e-03 | 111 | 200 | 5 | GO:0001750 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 5.99e-19 | 16 | 198 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 5.99e-19 | 16 | 198 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 6.81e-15 | 66 | 198 | 14 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 1.64e-14 | 70 | 198 | 14 | PS00972 |
| Domain | UCH | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.02e-14 | 71 | 198 | 14 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.02e-14 | 71 | 198 | 14 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.49e-14 | 72 | 198 | 14 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.49e-14 | 72 | 198 | 14 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.49e-14 | 72 | 198 | 14 | IPR001394 |
| Domain | Cadherin | DCHS2 CDHR1 CDH23 KIAA0319 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 4.61e-09 | 118 | 198 | 12 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 2.23e-08 | 109 | 198 | 11 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.26e-08 | 113 | 198 | 11 | PS00232 |
| Domain | Cadherin | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.26e-08 | 113 | 198 | 11 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.58e-08 | 114 | 198 | 11 | PS50268 |
| Domain | - | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.58e-08 | 114 | 198 | 11 | 2.60.40.60 |
| Domain | CA | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 3.92e-08 | 115 | 198 | 11 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDHR1 CDH23 FAT1 PCDH11Y CELSR3 CELSR2 DCHS1 CDH1 PCDH7 CDH17 | 4.29e-08 | 116 | 198 | 11 | IPR015919 |
| Domain | Spectrin | 3.67e-06 | 23 | 198 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 1.23e-05 | 29 | 198 | 5 | IPR002017 | |
| Domain | FN3_dom | MDGA2 KIAA0319 IL23R CNTN1 FN1 LRRN1 NRCAM KALRN TNN ROS1 SORL1 | 1.48e-05 | 209 | 198 | 11 | IPR003961 |
| Domain | FN3 | 2.90e-05 | 185 | 198 | 10 | SM00060 | |
| Domain | FN3 | 5.38e-05 | 199 | 198 | 10 | PS50853 | |
| Domain | DH_1 | 5.41e-05 | 63 | 198 | 6 | PS00741 | |
| Domain | fn3 | 5.90e-05 | 162 | 198 | 9 | PF00041 | |
| Domain | CH | 6.46e-05 | 65 | 198 | 6 | SM00033 | |
| Domain | - | 6.80e-05 | 95 | 198 | 7 | 2.60.120.200 | |
| Domain | ACTININ_2 | 9.26e-05 | 23 | 198 | 4 | PS00020 | |
| Domain | ACTININ_1 | 9.26e-05 | 23 | 198 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.26e-05 | 23 | 198 | 4 | IPR001589 | |
| Domain | RhoGEF | 9.82e-05 | 70 | 198 | 6 | PF00621 | |
| Domain | CH | 9.82e-05 | 70 | 198 | 6 | PF00307 | |
| Domain | DH_2 | 9.82e-05 | 70 | 198 | 6 | PS50010 | |
| Domain | - | 1.06e-04 | 71 | 198 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 1.06e-04 | 71 | 198 | 6 | IPR000219 | |
| Domain | - | 1.06e-04 | 71 | 198 | 6 | 1.10.418.10 | |
| Domain | MAGEA3/MAGEA6 | 1.12e-04 | 2 | 198 | 2 | IPR030097 | |
| Domain | CH | 1.24e-04 | 73 | 198 | 6 | PS50021 | |
| Domain | CH-domain | 1.44e-04 | 75 | 198 | 6 | IPR001715 | |
| Domain | SPEC | 3.49e-04 | 32 | 198 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.49e-04 | 32 | 198 | 4 | IPR018159 | |
| Domain | GPS | 4.43e-04 | 34 | 198 | 4 | SM00303 | |
| Domain | GPS | 4.96e-04 | 35 | 198 | 4 | PF01825 | |
| Domain | GPS | 5.53e-04 | 36 | 198 | 4 | PS50221 | |
| Domain | ConA-like_dom | 5.63e-04 | 219 | 198 | 9 | IPR013320 | |
| Domain | GPS | 6.15e-04 | 37 | 198 | 4 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 6.82e-04 | 38 | 198 | 4 | PS50025 | |
| Domain | GDS_CDC24_CS | 7.54e-04 | 39 | 198 | 4 | IPR001331 | |
| Domain | - | 7.54e-04 | 39 | 198 | 4 | 2.120.10.30 | |
| Domain | RhoGEF | 7.72e-04 | 68 | 198 | 5 | SM00325 | |
| Domain | GPCR_2_extracellular_dom | 8.31e-04 | 40 | 198 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 8.31e-04 | 40 | 198 | 4 | PS00649 | |
| Domain | Laminin_G_2 | 8.31e-04 | 40 | 198 | 4 | PF02210 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 8.31e-04 | 40 | 198 | 4 | PS50227 | |
| Domain | Protocadherin | 1.09e-03 | 5 | 198 | 2 | PF08374 | |
| Domain | Perilipin | 1.09e-03 | 5 | 198 | 2 | PF03036 | |
| Domain | Perilipin | 1.09e-03 | 5 | 198 | 2 | IPR004279 | |
| Domain | Protocadherin | 1.09e-03 | 5 | 198 | 2 | IPR013585 | |
| Domain | PDZ | 1.16e-03 | 151 | 198 | 7 | PS50106 | |
| Domain | MAGE_N | 1.17e-03 | 20 | 198 | 3 | SM01392 | |
| Domain | LamG | 1.19e-03 | 44 | 198 | 4 | SM00282 | |
| Domain | PDZ | 1.20e-03 | 152 | 198 | 7 | IPR001478 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.41e-03 | 46 | 198 | 4 | IPR011042 | |
| Domain | Ig-like_fold | IGSF6 MDGA2 KIAA0319 HAVCR1 IL23R CNTN1 FLNB TRIM2 FN1 LRRN1 NRCAM KALRN CCDC141 TNN ROS1 ALPK2 SORL1 | 1.43e-03 | 706 | 198 | 17 | IPR013783 |
| Domain | MAGE_N | 1.56e-03 | 22 | 198 | 3 | PF12440 | |
| Domain | MAGE_N | 1.56e-03 | 22 | 198 | 3 | IPR021072 | |
| Domain | DUSP | 1.63e-03 | 6 | 198 | 2 | PF06337 | |
| Domain | EFhand_Ca_insen | 1.63e-03 | 6 | 198 | 2 | PF08726 | |
| Domain | DUSP | 1.63e-03 | 6 | 198 | 2 | SM00695 | |
| Domain | EF-hand_Ca_insen | 1.63e-03 | 6 | 198 | 2 | IPR014837 | |
| Domain | - | IGSF6 MDGA2 HAVCR1 IL23R CNTN1 FLNB TRIM2 FN1 LRRN1 NRCAM KALRN CCDC141 TNN ROS1 ALPK2 SORL1 | 1.92e-03 | 663 | 198 | 16 | 2.60.40.10 |
| Domain | EGF-like_CS | 1.92e-03 | 261 | 198 | 9 | IPR013032 | |
| Domain | 7tm_2 | 1.93e-03 | 50 | 198 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.93e-03 | 50 | 198 | 4 | PS00650 | |
| Domain | DUSP | 2.27e-03 | 7 | 198 | 2 | PS51283 | |
| Domain | RBD | 2.27e-03 | 7 | 198 | 2 | SM00455 | |
| Domain | - | 2.27e-03 | 7 | 198 | 2 | 3.30.2230.10 | |
| Domain | RBD_dom | 2.27e-03 | 7 | 198 | 2 | IPR003116 | |
| Domain | RBD | 2.27e-03 | 7 | 198 | 2 | PS50898 | |
| Domain | Pept_C19_DUSP | 2.27e-03 | 7 | 198 | 2 | IPR006615 | |
| Domain | E2F | 3.00e-03 | 8 | 198 | 2 | IPR015633 | |
| Domain | Laminin_G | 3.33e-03 | 58 | 198 | 4 | IPR001791 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.02e-15 | 45 | 154 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.60e-09 | 191 | 154 | 15 | MM15289 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L20 SPTBN1 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 FN1 KALRN USP17L11 USP17L5 USP17L10 TLN1 USP17L6P RAPGEF2 USP17L22 USP17L15 | 1.17e-08 | 318 | 154 | 18 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 1.89e-08 | 221 | 154 | 15 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.79e-07 | 262 | 154 | 15 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 USP15 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 9.68e-07 | 299 | 154 | 15 | M27574 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-24 | 21 | 202 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.75e-24 | 22 | 202 | 13 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.37e-23 | 24 | 202 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.34e-23 | 33 | 202 | 14 | 20228807 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.83e-23 | 25 | 202 | 13 | 21115691 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 17109758 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 20368735 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.95e-23 | 34 | 202 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.63e-23 | 26 | 202 | 13 | 35816173 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.56e-23 | 35 | 202 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.56e-23 | 35 | 202 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.07e-22 | 36 | 202 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.71e-22 | 37 | 202 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.62e-22 | 29 | 202 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.70e-18 | 50 | 202 | 13 | 31806660 |
| Pubmed | NRIP1 ZBTB38 REPS1 SPTBN1 ACTN4 ACTN3 TTC3 WNK1 BIRC6 KARS1 ALMS1 NFIL3 ZBTB40 IPO5 FLNB FN1 ANK2 KALRN CCDC141 AKAP12 LRPPRC TLN1 SON | 2.33e-14 | 497 | 202 | 23 | 23414517 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 ADGRV1 TTC3 TASOR2 TBC1D14 BOD1L1 POLK USP15 ATF7 FLNB CACNB3 ANK3 LRRN1 PCDH11Y PELI2 FAM117B BTAF1 CEP192 ZMIZ1 TARS2 ARHGAP6 LRPPRC THADA KLK4 USF3 WDR11 ZNF827 SETD5 MICAL2 LIMCH1 LRBA RAPGEF2 VPS13B DOP1A ZC3HAV1 | 1.74e-12 | 1489 | 202 | 35 | 28611215 |
| Pubmed | DLGAP1 MAP1A ERC1 SPTBN1 ACTN4 ACTN3 KARS1 TTC7B AFDN SIPA1L2 DNAH6 CNTN1 IPO5 FLNB FN1 ANK2 ANK3 NRCAM KALRN PCLO ARPC1A ARHGEF12 POR DHX57 YTHDC2 PLEKHA6 SLC1A2 PRPF40A LRPPRC INA MICAL2 TLN1 LIMCH1 RAPGEF2 | 2.82e-12 | 1431 | 202 | 34 | 37142655 | |
| Pubmed | TPR HAUS6 ERC1 ACTN4 USP15 FLNB YTHDC2 PIKFYVE WDR11 TLN1 LIMCH1 LRBA PLIN3 ZC3HAV1 | 4.06e-11 | 216 | 202 | 14 | 31519766 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 MAP1A SPTBN1 ACTN4 CACNB3 ANK2 ANK3 NRCAM KALRN PCLO ARPC1A GRIA3 INA RAPGEF2 PCDH7 | 1.24e-10 | 281 | 202 | 15 | 28706196 |
| Pubmed | SPATA7 HAUS6 BIRC6 TASOR2 CEP350 FAT1 AFDN AFF2 FN1 ANK3 WRN ARFGEF1 POR MUC16 GPRIN3 CEP192 AKAP12 THADA WDR11 LRBA RAPGEF2 PCDH7 ZC3HAV1 | 2.01e-10 | 777 | 202 | 23 | 35844135 | |
| Pubmed | TPR HAUS6 REPS1 ERC1 SPTBN1 ARHGAP29 AFDN BOD1L1 IPO5 FLNB ANK2 ANK3 ARHGEF12 YTHDC2 PRPF40A AKAP12 LRPPRC TLN1 LRBA PCDH7 PLIN3 ZC3HAV1 | 2.07e-10 | 708 | 202 | 22 | 39231216 | |
| Pubmed | ERC1 KIAA0319 BOD1L1 SIPA1L2 USP15 NRCAM ARHGEF12 ALS2 CEP192 EPG5 SETD5 TLN1 LIMCH1 TRAK2 SYVN1 VPS13B SON | 3.16e-10 | 407 | 202 | 17 | 12693553 | |
| Pubmed | TPR HAUS6 ZNF148 REPS1 ERC1 ALMS1 AFDN BOD1L1 USP15 ANK3 HEATR1 PRPF40A KMT2D TLN1 LRBA PCBP2 PLIN3 TPD52 ZC3HAV1 | 6.47e-10 | 549 | 202 | 19 | 38280479 | |
| Pubmed | TPR ERC1 SPTBN1 NHLRC2 USP15 FLNB ARID4A POR YTHDC2 AKAP12 WDR11 TLN1 TMED8 LIMCH1 LRBA VPS13B PLIN3 TPD52 ZC3HAV1 | 1.13e-09 | 568 | 202 | 19 | 37774976 | |
| Pubmed | TPR SPTBN1 ACTN4 BIRC6 TASOR2 KARS1 AFDN CLUH IPO5 FLNB FN1 DHX57 YTHDC2 HEATR1 PRPF40A LRPPRC INA TLN1 SON ZC3HAV1 | 1.84e-09 | 653 | 202 | 20 | 22586326 | |
| Pubmed | TPR DLGAP1 ERC1 SPTBN1 TTC3 KIAA0319 AFDN UNC79 CNTN1 ANK2 ANK3 NRCAM KALRN ARHGEF12 GRIA3 SLC1A2 AKAP12 LRPPRC INA CELSR2 ZNF516 DCHS1 LIMCH1 RAPGEF2 | 2.42e-09 | 963 | 202 | 24 | 28671696 | |
| Pubmed | TPR ZBTB6 SPTBN1 ACTN4 TTC3 WNK1 TIAM2 HAVCR1 ZBTB40 BOD1L1 POLK SUCO DMTF1 FLNB ZWILCH FN1 ANK3 ALS2 CEP192 HEATR1 AKAP12 SETD5 ZMYM1 CDH1 VPS13B | 5.18e-09 | 1084 | 202 | 25 | 11544199 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR HAUS6 ZNF148 REPS1 MAP1A ERC1 WNK1 KARS1 ALMS1 BOD1L1 SIPA1L2 ANK2 YTHDC2 BTAF1 HEATR1 PRPF40A AKAP12 TLN1 LRBA PCBP2 PLIN3 SON ZC3HAV1 | 6.67e-09 | 934 | 202 | 23 | 33916271 |
| Pubmed | ZBTB6 SPTBN1 TTC3 SOX7 AFDN DMTF1 FLNB KRT7 FN1 ANK3 PRPF40A EPG5 KMT2D ZNF41 CSPG4 PCBP2 PLIN3 SON | 1.35e-08 | 591 | 202 | 18 | 15231748 | |
| Pubmed | NRIP1 DLGAP1 DCHS2 ZBTB38 REPS1 ERC1 SPTBN1 ACTN4 TTC3 CEP350 TTC7B OTOF AFDN IPO5 FLNB SUPT20H FN1 ANK2 ANK3 NRCAM KALRN CELSR3 TIAM1 MICAL2 LRBA RAPGEF2 | 3.53e-08 | 1285 | 202 | 26 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERC1 SPTBN1 WNK1 CEP350 FSIP2 ALMS1 AFDN BOD1L1 SIPA1L2 ARHGEF28 ALS2 FAM117B CEP192 LRPPRC INA TIAM1 LIMCH1 RAPGEF2 PCDH7 DOP1A ZC3HAV1 | 3.71e-08 | 861 | 202 | 21 | 36931259 |
| Pubmed | HAUS6 WNK1 BIRC6 USP20 CEP350 SMYD4 ALMS1 ARHGEF28 LRRN1 GPRIN3 PLEKHA6 PIKFYVE THADA USF3 WDR11 DOP1A | 3.73e-08 | 493 | 202 | 16 | 15368895 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAP1A TSC22D2 WNK1 TASOR2 DMTF1 AFF2 ANK3 LRRN1 CCDC141 ARHGAP6 USF3 TLN1 ZMYM1 GPRC5B SON | 3.95e-08 | 430 | 202 | 15 | 35044719 |
| Pubmed | MAP1A ERC1 ACTN4 CEP350 ALMS1 ARHGAP29 SIPA1L2 ARHGEF12 YTHDC2 CEP192 TRAK2 | 4.52e-08 | 209 | 202 | 11 | 36779422 | |
| Pubmed | TPR DLGAP1 MAP1A ERC1 SPTBN1 ACTN4 BIRC6 SLC39A6 AFDN SIPA1L2 USP15 FLNB ANK2 ANK3 NRCAM KALRN PCLO POR GRIA3 SLC1A2 LRPPRC INA CELSR2 GABBR1 | 5.87e-08 | 1139 | 202 | 24 | 36417873 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NRIP1 METTL3 MAP1A ERC1 E2F7 CNTLN WNK1 ALMS1 SIPA1L2 POLK HSF2 SUPT20H CEP192 PIKFYVE ZNF516 PCBP2 SORL1 | 7.30e-08 | 588 | 202 | 17 | 38580884 |
| Pubmed | ANKRD31 USP17L21 DLGAP1 USP17L20 USP17L19 CNTLN USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 GRIA3 USP17L10 KMT2D USP17L6P USP17L22 USP17L15 | 9.73e-08 | 674 | 202 | 18 | 37196079 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | REPS1 LAMC3 TTC3 WNK1 BIRC6 TIAM2 FAT1 SIPA1L2 KALRN BTAF1 CEP192 PIKFYVE THADA KMT2D CELSR3 CELSR2 ZNF827 SETD5 TLN1 CSPG4 ZNF516 LRBA SYVN1 | 1.41e-07 | 1105 | 202 | 23 | 35748872 |
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 1.93e-07 | 3 | 202 | 3 | 17620337 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 11597768 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ERC1 SPTBN1 ARHGAP29 AFDN USP15 FLNB ANK3 ARHGEF12 PLEKHA6 TLN1 LIMCH1 PCBP2 CDH1 PLIN3 TPD52 ZC3HAV1 | 2.37e-07 | 565 | 202 | 16 | 25468996 |
| Pubmed | HAUS6 METTL3 ERC1 WNK1 CEP350 KARS1 ALMS1 USP15 FLNB CNOT11 SUPT20H ARID4A TLN1 ZNF516 LRBA PLIN3 TPD52 | 2.69e-07 | 645 | 202 | 17 | 25281560 | |
| Pubmed | DLGAP1 SPTBN1 CNTN1 ANK2 ANK3 KALRN GRIA3 SLC1A2 LRPPRC INA RAPGEF2 | 2.87e-07 | 251 | 202 | 11 | 27507650 | |
| Pubmed | ERC1 SPTBN1 ANKRD30B ACTN4 ACTN3 TTC3 TASOR2 BOD1L1 SIPA1L2 DNAH6 FLNB KRT7 ANK2 PCLO DHX57 GRIA3 HEATR1 LRPPRC INA SETD5 TNN CSPG4 MTTP LIMCH1 CDH1 DOP1A | 3.30e-07 | 1442 | 202 | 26 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ZNF148 SPTBN1 FBXO4 ZBTB40 AFDN CLUH ARID4A YTHDC2 BTAF1 PRPF40A KMT2D ZNF516 LIMCH1 PCDH7 CDH17 SON ZC3HAV1 | 7.29e-07 | 774 | 202 | 18 | 15302935 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SPATA7 HAUS6 ERC1 CDH23 ACTN4 WNK1 KARS1 CEP120 AFDN USP15 CLUH CNOT11 ANK3 PIGS WRN FAM117B HEATR1 AKAP12 LRPPRC THADA TIAM1 SETD5 ZC3HAV1 SORL1 | 8.53e-07 | 1321 | 202 | 24 | 27173435 |
| Pubmed | TPR HAUS6 METTL3 ZNF148 GATAD2A ERC1 WNK1 AFDN USP15 FLNB KALRN PLEKHA6 SON ZC3HAV1 | 1.68e-06 | 503 | 202 | 14 | 16964243 | |
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 1.90e-06 | 16 | 202 | 4 | 21745462 | |
| Pubmed | Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. | 1.91e-06 | 5 | 202 | 3 | 16061471 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 8037761 | ||
| Pubmed | ZNF148 SPTBN1 TTC3 SLC39A6 SIPA1L2 SUCO CLUH ANK2 ANK3 POR FASTKD2 CEP192 HEATR1 TARS2 PRPF40A AKAP12 LRPPRC THADA TIAM1 WDR11 TLN1 PCDH7 VPS13B TPD52 ZC3HAV1 | 2.00e-06 | 1487 | 202 | 25 | 33957083 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ERC1 SPTBN1 E2F7 LAMC3 TTC3 POLK SUCO ZWILCH KRT7 ARHGEF28 ARID4A POR TARS2 EPG5 THADA TLN1 LIMCH1 ZMYM1 ZC3HAV1 | 2.22e-06 | 925 | 202 | 19 | 28986522 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.17e-06 | 18 | 202 | 4 | 12119179 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 22693585 | ||
| Pubmed | 4.37e-06 | 332 | 202 | 11 | 37433992 | ||
| Pubmed | TPR BOD1L1 PIGS DHX57 YTHDC2 HEATR1 TARS2 LRPPRC PCBP2 SON ZC3HAV1 | 4.50e-06 | 333 | 202 | 11 | 36779763 | |
| Pubmed | TPR ZNF148 CLUH IPO5 ANK3 E2F1 FASTKD2 LRPPRC SCUBE2 MICAL2 TLN1 ZMYM1 CDH1 PLIN3 ZC3HAV1 | 5.15e-06 | 634 | 202 | 15 | 34591612 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HAUS6 MAP1A ERC1 TTC3 CEP350 CLUH CNOT11 DHX57 YTHDC2 AKAP12 TLN1 ZMYM1 PCBP2 PLIN3 SON ZC3HAV1 | 5.86e-06 | 724 | 202 | 16 | 36232890 |
| Pubmed | TPR DLGAP1 MAP1A SPTBN1 ACTN4 WNK1 CEP350 SUPT20H ANK3 PLEKHA6 SLC1A2 USF3 RAPGEF2 | 6.09e-06 | 486 | 202 | 13 | 20936779 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.12e-06 | 344 | 202 | 11 | 30333137 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 | 6.50e-06 | 119 | 202 | 7 | 28625976 |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 16059920 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 6.64e-06 | 7 | 202 | 3 | 7495297 | |
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 6.64e-06 | 7 | 202 | 3 | 18197853 | |
| Pubmed | TPR NRIP1 HAUS6 ZNF148 ERC1 BIRC6 ALMS1 FLNB ZMIZ1 KMT2D ZNF516 LRBA | 6.90e-06 | 418 | 202 | 12 | 34709266 | |
| Pubmed | 7.40e-06 | 225 | 202 | 9 | 12168954 | ||
| Pubmed | TTC7B SLC39A6 SIPA1L2 ANK3 GPRIN3 PLEKHA6 AKAP12 LRPPRC CELSR2 LRBA PCDH7 ZC3HAV1 | 7.41e-06 | 421 | 202 | 12 | 36976175 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ZNF148 ERC1 CDH23 FAT1 OTOF DNAH6 ANK3 ARHGEF12 YTHDC2 CELSR3 SON | 9.63e-06 | 361 | 202 | 11 | 26167880 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | GATAD2A WNK1 BIRC6 SMYD4 POLK CNTN1 IPO5 CACNB3 SUPT20H FN1 ALS2 | 1.01e-05 | 363 | 202 | 11 | 14691545 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR SPTBN1 LAMC3 ACTN4 TTC3 KARS1 AFDN BOD1L1 CLUH IPO5 FLNB PCLO ARPC1A POR YTHDC2 FASTKD2 HEATR1 TARS2 PRPF40A LRPPRC THADA TLN1 ZC3HAV1 | 1.02e-05 | 1425 | 202 | 23 | 30948266 |
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 1.06e-05 | 8 | 202 | 3 | 31149633 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 1.06e-05 | 8 | 202 | 3 | 27226137 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 1.07e-05 | 24 | 202 | 4 | 26116661 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HAUS6 ERC1 ACTN4 CNTLN CEP350 CEP120 ALMS1 ARHGAP29 AFDN SIPA1L2 USP15 CEP192 INA WDR11 TLN1 PCBP2 ZC3HAV1 | 1.14e-05 | 853 | 202 | 17 | 28718761 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.32e-05 | 184 | 202 | 8 | 32908313 | |
| Pubmed | 1.33e-05 | 242 | 202 | 9 | 34011540 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR ERC1 SPTBN1 ACTN4 NHLRC2 KARS1 AFDN IPO5 FLNB ANK3 PRPF40A AKAP12 LRPPRC INA TLN1 LIMCH1 PCBP2 PLIN3 TPD52 ZC3HAV1 | 1.38e-05 | 1149 | 202 | 20 | 35446349 |
| Pubmed | TPR SLC39A6 AFDN USP15 IPO5 ANK2 PIGS ARHGEF12 AKAP12 TLN1 LRBA ZC3HAV1 | 1.41e-05 | 449 | 202 | 12 | 31732153 | |
| Pubmed | Discovery of tissue-specific exons using comprehensive human exon microarrays. | 1.58e-05 | 9 | 202 | 3 | 17456239 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.07e-05 | 256 | 202 | 9 | 33397691 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ERC1 SPTBN1 ACTN4 NHLRC2 UNC79 IPO5 FLNB AFF2 ANK3 PCLO GPRIN3 EPG5 LRPPRC TLN1 LRBA PCBP2 | 2.22e-05 | 807 | 202 | 16 | 30575818 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.25e-05 | 10 | 202 | 3 | 22159418 | |
| Pubmed | Drebrin, an actin-binding protein, is required for lens morphogenesis and growth. | 2.25e-05 | 10 | 202 | 3 | 33896079 | |
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 17329413 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NRIP1 ZNF148 GATAD2A E2F7 SOX7 SUPT20H PCLO LRPPRC KMT2D ZNF516 ZMYM1 | 2.37e-05 | 398 | 202 | 11 | 35016035 |
| Interaction | AGAP2 interactions | DLGAP1 MAP1A SPTBN1 ACTN4 CACNB3 ANK2 ANK3 NRCAM KALRN PCLO ARPC1A INA RAPGEF2 PCDH7 | 2.33e-08 | 210 | 199 | 14 | int:AGAP2 |
| Interaction | PFN1 interactions | TPR MAP1A ERC1 SPTBN1 NHLRC2 WNK1 BIRC6 CEP350 ALMS1 ARHGAP29 AFDN BOD1L1 SIPA1L2 FN1 ANK2 PCLO ARHGEF12 CEP192 THADA LIMCH1 CDH1 | 3.61e-08 | 509 | 199 | 21 | int:PFN1 |
| Interaction | XAGE1A interactions | 1.39e-07 | 41 | 199 | 7 | int:XAGE1A | |
| Interaction | VASP interactions | REPS1 MAP1A ACTN4 NHLRC2 CEP350 FAT1 ALMS1 SIPA1L2 FN1 DCAF8L2 ARHGEF12 CEP192 PRPF40A LIMCH1 CDH1 | 2.47e-07 | 294 | 199 | 15 | int:VASP |
| Interaction | KCNA3 interactions | TPR NRIP1 HAUS6 REPS1 ERC1 SPTBN1 ARHGAP29 AFDN BOD1L1 IPO5 FLNB AFF2 ANK2 ANK3 ARHGEF12 YTHDC2 PRPF40A AKAP12 LRPPRC TLN1 LRBA PCDH7 PLIN3 DOP1A ZC3HAV1 SORL1 | 5.00e-07 | 871 | 199 | 26 | int:KCNA3 |
| Interaction | KCTD13 interactions | DLGAP1 MAP1A ERC1 SPTBN1 ACTN4 ACTN3 KARS1 TTC7B AFDN SIPA1L2 DNAH6 CNTN1 IPO5 FLNB FN1 ANK2 ANK3 NRCAM KALRN PCLO ARPC1A ARHGEF12 POR DHX57 YTHDC2 PLEKHA6 SLC1A2 PRPF40A LRPPRC INA MICAL2 TLN1 LIMCH1 RAPGEF2 | 8.47e-07 | 1394 | 199 | 34 | int:KCTD13 |
| Interaction | KRT8 interactions | ERC1 TTC3 BIRC6 CEP350 ALMS1 SIPA1L2 CLUH KRT7 FN1 ARHGEF12 ARFGEF1 CEP192 THADA INA SYVN1 CDH1 PCDH7 | 1.94e-06 | 441 | 199 | 17 | int:KRT8 |
| Interaction | NUP210P1 interactions | 3.35e-06 | 42 | 199 | 6 | int:NUP210P1 | |
| Interaction | LOC254896 interactions | 3.87e-06 | 43 | 199 | 6 | int:LOC254896 | |
| Interaction | C2CD4B interactions | 4.44e-06 | 44 | 199 | 6 | int:C2CD4B | |
| Interaction | RAPGEF4 interactions | 9.51e-06 | 50 | 199 | 6 | int:RAPGEF4 | |
| Interaction | ATF7IP interactions | 9.53e-06 | 138 | 199 | 9 | int:ATF7IP | |
| Interaction | EZR interactions | HAUS6 REPS1 ACTN4 KARS1 SLC39A6 IPO5 FN1 ANK2 ANK3 ARHGEF12 AKAP12 INA LIMCH1 LRBA PCBP2 CDH1 PCDH7 TPD52 | 1.01e-05 | 553 | 199 | 18 | int:EZR |
| Interaction | CEP120 interactions | 1.04e-05 | 106 | 199 | 8 | int:CEP120 | |
| Interaction | NAA40 interactions | TPR HAUS6 ZNF148 REPS1 MAP1A ERC1 WNK1 KARS1 ALMS1 BOD1L1 SIPA1L2 ANK2 YTHDC2 BTAF1 HEATR1 PRPF40A AKAP12 WDR11 TLN1 LIMCH1 LRBA PCBP2 PLIN3 SON ZC3HAV1 | 1.29e-05 | 978 | 199 | 25 | int:NAA40 |
| Interaction | KRT18 interactions | METTL3 ERC1 BIRC6 CEP350 ALMS1 SIPA1L2 CNTN1 IPO5 FLNB KRT7 FN1 CEP192 INA CDH1 PCDH7 | 1.91e-05 | 419 | 199 | 15 | int:KRT18 |
| Interaction | LAG3 interactions | 1.99e-05 | 17 | 199 | 4 | int:LAG3 | |
| Interaction | ZYX interactions | ACTN4 NHLRC2 TSC22D2 WNK1 CEP350 ALMS1 SIPA1L2 FN1 ANK2 ALS2 CEP192 LIMCH1 CDH1 | 2.51e-05 | 329 | 199 | 13 | int:ZYX |
| Interaction | DCANP1 interactions | 3.18e-05 | 19 | 199 | 4 | int:DCANP1 | |
| Interaction | GBF1 interactions | TPR HAUS6 ERC1 ACTN4 BIRC6 USP15 FLNB YTHDC2 PIKFYVE WDR11 TLN1 LIMCH1 LRBA PLIN3 ZC3HAV1 | 3.53e-05 | 442 | 199 | 15 | int:GBF1 |
| Interaction | HDAC1 interactions | MAGEA3 TPR NRIP1 HAUS6 METTL3 ZNF148 GATAD2A ERC1 BIRC6 ALMS1 USP15 IPO5 FLNB FN1 ARID4A WRN ARFGEF1 E2F1 ZMIZ1 LRPPRC KMT2D ZNF827 TLN1 ZNF516 LRBA CDH1 | 3.72e-05 | 1108 | 199 | 26 | int:HDAC1 |
| Interaction | YWHAQ interactions | TPR NRIP1 DLGAP1 ZBTB38 ERC1 WNK1 CEP350 AFDN SIPA1L2 SUCO UNC79 ARHGEF28 FN1 E2F1 ALS2 FAM117B CEP192 LRPPRC INA TIAM1 TLN1 LRBA RAPGEF2 PCDH7 DOP1A TPD52 | 4.32e-05 | 1118 | 199 | 26 | int:YWHAQ |
| Interaction | KALRN interactions | 4.67e-05 | 96 | 199 | 7 | int:KALRN | |
| Interaction | TOP3B interactions | REPS1 LAMC3 ACTN4 TTC3 WNK1 BIRC6 TIAM2 FAT1 KARS1 SIPA1L2 IPO5 CNOT11 KALRN ARPC1A WRN DHX57 BTAF1 CEP192 PIKFYVE THADA KMT2D CELSR3 CELSR2 ZNF827 SETD5 TLN1 CSPG4 ZNF516 LRBA SYVN1 ZC3HAV1 | 4.85e-05 | 1470 | 199 | 31 | int:TOP3B |
| Interaction | SIRT7 interactions | TPR SPTBN1 ACTN4 BIRC6 TASOR2 KARS1 AFDN CLUH IPO5 FLNB FN1 DHX57 YTHDC2 HEATR1 PRPF40A LRPPRC INA TLN1 SON ZC3HAV1 | 5.04e-05 | 744 | 199 | 20 | int:SIRT7 |
| Interaction | CEP152 interactions | 7.45e-05 | 179 | 199 | 9 | int:CEP152 | |
| Interaction | WWTR1 interactions | HAUS6 ERC1 ALMS1 AFDN USP15 ANK3 HEATR1 PRPF40A KMT2D TLN1 LRBA PLIN3 TPD52 ZC3HAV1 | 8.22e-05 | 422 | 199 | 14 | int:WWTR1 |
| Interaction | CIT interactions | TPR NRIP1 DLGAP1 HAUS6 ERC1 SPTBN1 ACTN4 ACTN3 ADGRV1 TTC3 BIRC6 ALMS1 BOD1L1 IPO5 FLNB KALRN PCLO POR DHX57 YTHDC2 HEATR1 PLEKHA6 PRPF40A LRPPRC INA CELSR2 SETD5 PCBP2 SON ZC3HAV1 | 9.20e-05 | 1450 | 199 | 30 | int:CIT |
| Interaction | YWHAG interactions | DLGAP1 ERC1 SPTBN1 ACTN4 CNTLN WNK1 CEP350 ALMS1 ARHGAP29 AFDN BOD1L1 SIPA1L2 SUCO ARHGEF28 FN1 ALS2 FAM117B CEP192 PRPF40A INA TIAM1 LRBA RAPGEF2 PCDH7 DOP1A SON ZC3HAV1 | 1.03e-04 | 1248 | 199 | 27 | int:YWHAG |
| Interaction | DLG4 interactions | DLGAP1 MAP1A SPTBN1 CNTN1 ANK2 ANK3 NRCAM KALRN GRIA3 ALS2 SLC1A2 LRPPRC INA TIAM1 | 1.57e-04 | 449 | 199 | 14 | int:DLG4 |
| Interaction | PPP1R9B interactions | DLGAP1 MAP1A SPTBN1 ACTN4 TIAM2 BOD1L1 CNTN1 CACNB3 ANK2 ANK3 PCLO ARPC1A FASTKD2 SLC1A2 INA TIAM1 PCBP2 | 1.67e-04 | 626 | 199 | 17 | int:PPP1R9B |
| Interaction | ODF2 interactions | 1.79e-04 | 158 | 199 | 8 | int:ODF2 | |
| Interaction | OFD1 interactions | HAUS6 ERC1 NHLRC2 CEP350 KARS1 CEP120 AFDN IPO5 CNOT11 CEP192 AKAP12 TRAK2 | 1.82e-04 | 347 | 199 | 12 | int:OFD1 |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 TBC1D14 BOD1L1 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.82e-22 | 79 | 202 | 16 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 TBC1D14 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.83e-14 | 222 | 202 | 15 | chr4p16 |
| Cytoband | 4q31.3 | 3.44e-04 | 31 | 202 | 3 | 4q31.3 | |
| GeneFamily | Cadherin related | 1.15e-07 | 17 | 133 | 5 | 24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.25e-04 | 66 | 133 | 5 | 722 | |
| GeneFamily | PDZ domain containing | 1.33e-04 | 152 | 133 | 7 | 1220 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.60e-04 | 3 | 133 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.60e-04 | 3 | 133 | 2 | 1189 | |
| GeneFamily | Fibronectin type III domain containing | 1.82e-04 | 160 | 133 | 7 | 555 | |
| GeneFamily | Actinins | 3.19e-04 | 4 | 133 | 2 | 1112 | |
| GeneFamily | Perilipins | 5.29e-04 | 5 | 133 | 2 | 678 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.23e-03 | 161 | 133 | 6 | 593 | |
| GeneFamily | E2F transcription factors | 1.46e-03 | 8 | 133 | 2 | 982 | |
| GeneFamily | Actins|Deafness associated genes | 1.49e-03 | 113 | 133 | 5 | 1152 | |
| GeneFamily | MAGE family | 3.15e-03 | 40 | 133 | 3 | 1136 | |
| GeneFamily | Non-clustered protocadherins | 3.38e-03 | 12 | 133 | 2 | 21 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 6.26e-03 | 51 | 133 | 3 | 870 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.14e-13 | 86 | 201 | 13 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 TPD52 | 1.92e-13 | 112 | 201 | 14 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 ANK3 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.66e-11 | 160 | 201 | 14 | MM1155 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NRIP1 HAUS6 ZBTB38 ZNF148 TASOR2 KIAA0319 CEP350 SLC39A6 POLK SUCO IPO5 TRIM2 WRN ARFGEF1 CEP192 WDR11 ZMYM1 CDH1 TPD52 SON SORL1 | 3.90e-08 | 656 | 201 | 21 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 ZNF148 ERC1 TSC22D2 CEP350 FAT1 ARHGAP29 SUCO USP15 FLNB TRIM2 SUPT20H ARID4A WRN ARFGEF1 BTAF1 ZMIZ1 PIKFYVE LRPPRC TIAM1 MICAL2 RAPGEF2 VPS13B SON | 4.85e-08 | 856 | 201 | 24 | M4500 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | TPR USP17L21 GATAD2A USP17L20 USP17L19 TIAM2 USP17L18 USP17L17 AFDN USP17L13 USP17L12 FN1 USP17L11 POR USP17L5 E2F1 ALS2 FAM117B USP17L10 PRPF40A EPG5 PIKFYVE CELSR3 TLN1 USP17L6P USP17L22 USP17L15 PLIN3 | 1.55e-07 | 1198 | 201 | 28 | MM1062 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ZBTB38 MDGA2 TTC3 FSIP2 BOD1L1 UNC79 CNTN1 CACNB3 TRIM2 AFF2 ANK2 ANK3 ARID4A PCLO ARHGEF12 ARFGEF1 GPRIN3 FAM117B PLEKHA6 ZMIZ1 CCDC141 SLC1A2 INA CELSR3 PCDH7 DOP1A | 4.03e-07 | 1106 | 201 | 26 | M39071 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | SPTBN1 ACTN4 ALMS1 ARHGAP29 FLNB ARHGEF12 ARFGEF1 ALS2 CEP192 LRPPRC TIAM1 | 4.29e-07 | 199 | 201 | 11 | M5893 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 ZNF148 CEP350 FAT1 ARHGAP29 FLNB TRIM2 WRN ARFGEF1 ZMIZ1 PIKFYVE LRPPRC TIAM1 LIMCH1 RAPGEF2 | 3.47e-06 | 466 | 201 | 15 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NRIP1 ZNF148 CEP350 FAT1 SUCO DMTF1 ZMIZ1 PIKFYVE MICAL2 RAPGEF2 VPS13B DOP1A | 3.85e-06 | 300 | 201 | 12 | M8702 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.11e-05 | 180 | 201 | 9 | M8239 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L20 USP17L19 USP20 USP17L18 USP17L17 POLK USP17L13 USP17L12 USP17L11 USP17L5 E2F1 ALS2 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-05 | 647 | 201 | 17 | MM981 |
| Coexpression | KRAS.KIDNEY_UP.V1_UP | 1.31e-05 | 140 | 201 | 8 | M2892 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP | 1.50e-05 | 187 | 201 | 9 | M3287 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | NRIP1 TSC22D2 ALMS1 AP5Z1 SUPT20H PRPF40A TIAM1 TRAK2 VPS13B | 2.56e-05 | 200 | 201 | 9 | M8030 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR HAUS6 ZBTB38 ZNF148 WNK1 BIRC6 USP20 CEP350 BOD1L1 USP15 DMTF1 SELPLG ARID4A GPRIN3 YTHDC2 BTAF1 PRPF40A EPG5 PIKFYVE KMT2D SETD5 TLN1 LRBA VPS13B SON ZC3HAV1 SORL1 | 3.03e-05 | 1492 | 201 | 27 | M40023 |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP | 3.92e-05 | 163 | 201 | 8 | M6329 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | SPTBN1 ACTN4 TSC22D2 PTCHD1 FAT1 PLIN5 FLNB KRT7 MICAL2 LIMCH1 PCDH7 GABBR1 | 4.26e-05 | 382 | 201 | 12 | M38972 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZBTB38 MAP1A TTC3 TTC7B SIPA1L2 SUCO UNC79 TRIM2 NRCAM PCLO PLEKHA6 ZMIZ1 PIKFYVE LRPPRC USF3 INA TIAM1 PCDH7 TPD52 SORL1 | 4.36e-05 | 946 | 201 | 20 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.56e-05 | 221 | 201 | 9 | M39222 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 NRIP1 USP17L20 USP17L19 USP17L18 CEP120 USP17L17 USP17L13 SUPT20H USP17L12 USP17L11 ARHGEF12 USP17L5 USP17L10 PRPF40A PIKFYVE SETD5 USP17L6P USP17L22 USP17L15 ZC3HAV1 | 8.27e-05 | 1072 | 201 | 21 | MM1031 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | MAP1A SPTBN1 KIAA0319 HSF2 CACNB3 TRIM2 ANK2 ANK3 PCLO GRIA3 INA CELSR2 LIMCH1 | 1.09e-04 | 488 | 201 | 13 | M39104 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.33e-04 | 145 | 201 | 7 | M1810 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MAGEA3 TPR MAGEA12 HAUS6 ZBTB38 E2F7 TSC22D2 TTC3 BOD1L1 USP15 ZWILCH FN1 BTAF1 PRPF40A CELSR3 MICAL2 | 1.50e-04 | 721 | 201 | 16 | M10237 |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 1.58e-04 | 199 | 201 | 8 | M8111 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.58e-04 | 199 | 201 | 8 | M9443 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 1.58e-04 | 199 | 201 | 8 | M3257 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.58e-04 | 199 | 201 | 8 | M6264 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.63e-04 | 200 | 201 | 8 | M8032 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP | 1.63e-04 | 200 | 201 | 8 | M6065 | |
| Coexpression | GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP | 1.63e-04 | 200 | 201 | 8 | M5772 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 1.70e-04 | 256 | 201 | 9 | M828 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 1.78e-04 | 152 | 201 | 7 | MM488 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 1.78e-04 | 152 | 201 | 7 | M366 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 2.13e-04 | 208 | 201 | 8 | M39233 | |
| Coexpression | CHYLA_CBFA2T3_TARGETS_UP | IGSF6 SPTBN1 SMYD4 SELPLG KRT7 ANK3 KALRN PELI2 GRIA3 THADA THNSL2 | 2.17e-04 | 388 | 201 | 11 | M2205 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | E2F7 TTC3 SYCE2 SMYD4 ALMS1 HSF2 UNC79 IPO5 ZWILCH CACNB3 NRCAM INA CELSR3 CELSR2 CKAP2L | 2.58e-04 | 680 | 201 | 15 | MM456 |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN | 2.65e-04 | 115 | 201 | 6 | M19849 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MDGA2 CACNB3 AFF2 ANK2 ANK3 KALRN FAM117B PLEKHA6 INA CELSR3 ZC3H12C PCDH7 | 2.68e-04 | 465 | 201 | 12 | M39066 |
| Coexpression | MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS | 2.79e-04 | 17 | 201 | 3 | M15055 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | ZBTB6 UNC79 CACNB3 ANK2 ANK3 FAM117B PLEKHA6 SLC1A2 INA CELSR3 | 2.80e-04 | 335 | 201 | 10 | M39065 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 TPR REPS1 CNTLN WNK1 SYCE2 TTC7B BOD1L1 KRT7 AFF2 ARID4A ARFGEF1 POR PRPF40A KLK4 CKAP2L ZMYM1 LRBA | 6.64e-08 | 432 | 189 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SPATA7 TPR REPS1 CNTLN WNK1 SYCE2 HAVCR1 TTC7B BOD1L1 KRT7 AFF2 ARID4A PCLO ARHGEF12 ARFGEF1 POR SLC1A2 PRPF40A KLK4 TIAM1 CKAP2L LIMCH1 ZMYM1 LRBA PLIN3 | 2.54e-06 | 989 | 189 | 25 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR NRIP1 GATAD2A WNK1 BIRC6 CEP350 CNTN1 ANK2 ANK3 LRRN1 NRCAM KALRN ZMIZ1 ARHGAP6 INA CELSR3 SETD5 CDH1 VPS13B GPRC5B SON SORL1 | 4.02e-06 | 818 | 189 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 REPS1 WNK1 SYCE2 BOD1L1 HSF2 DMTF1 LRRN1 ARID4A PCLO ARHGEF12 ARFGEF1 SLC1A2 CELSR2 SETD5 MICAL2 RAPGEF2 SON | 6.61e-06 | 595 | 189 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 MAP1A MDGA2 ADGRV1 ALMS1 BOD1L1 USP15 ZWILCH LRRN1 NRCAM ARID4A PIGS PCLO USP17L10 HEATR1 SLC1A2 USF3 SCUBE2 INA CELSR2 CKAP2L ZC3H12C LRBA CDH1 | 8.15e-06 | 989 | 189 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | CDHR1 ACTN3 FAT1 IL23R FLNB KRT7 FN1 GRIA3 LPO SLC5A8 CDH1 PCDH7 CDH17 | 4.25e-05 | 384 | 189 | 13 | GSM777041_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SPATA7 TPR HAUS6 REPS1 WNK1 SYCE2 CEP120 TTC7B HSF2 ARID4A ARFGEF1 HEATR1 THADA SETD5 RAPGEF2 PLIN3 | 4.75e-05 | 564 | 189 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 REPS1 MDGA2 CNTLN WNK1 SYCE2 BOD1L1 HSF2 LRRN1 ARID4A ARHGEF12 POR PRPF40A SETD5 ZMYM1 RAPGEF2 SON | 5.01e-05 | 629 | 189 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | SPATA7 TPR ADGRV1 CNTLN TIAM2 HAVCR1 PTCHD1 TTC7B TBC1D14 ZWILCH KRT7 PCLO USP17L10 SLC1A2 PRPF40A SCUBE2 INA CELSR2 MICAL2 CKAP2L LIMCH1 PCDH7 | 6.32e-05 | 979 | 189 | 22 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 TPR MAP1A ERC1 E2F7 MDGA2 CNTLN ALMS1 BOD1L1 HSF2 ZWILCH ANK2 LRRN1 E2F1 USP17L10 CEP192 HEATR1 PRPF40A CELSR2 SETD5 CKAP2L ZC3H12C ZMYM1 | 7.25e-05 | 1060 | 189 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | CDHR1 ACTN3 FAT1 IL23R FLNB KRT7 FN1 GRIA3 LPO SLC5A8 CDH1 PCDH7 CDH17 | 8.46e-05 | 411 | 189 | 13 | GSM854302_500 |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | NRIP1 HAUS6 ABCA4 E2F7 SMYD4 FAT1 CEP120 TTC7B PLIN5 ARHGAP29 SLC39A6 BOD1L1 HSF2 SUCO IPO5 LRRN1 WRN PELI2 DHX57 E2F1 BTAF1 HEATR1 AKAP12 THADA CELSR2 TIAM1 LIMCH1 SORL1 | 1.22e-04 | 1479 | 189 | 28 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 TPR MAP1A ERC1 E2F7 MDGA2 ADGRV1 CNTLN ALMS1 BOD1L1 HSF2 ZWILCH AFF2 ANK2 LRRN1 NRCAM E2F1 USP17L10 CEP192 HEATR1 PLEKHA6 PRPF40A CELSR2 SETD5 CKAP2L ZC3H12C ZMYM1 | 1.43e-04 | 1414 | 189 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | MAP1A ADGRV1 PTCHD1 TRIM2 AFF2 LRRN1 NRCAM ARID4A PCLO ZMIZ1 SLC1A2 INA CELSR2 ZC3H12C | 1.50e-04 | 496 | 189 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | SPATA7 REPS1 MAP1A ADGRV1 WNK1 SYCE2 TTC7B AFF2 LRRN1 NRCAM ARID4A PCLO ARHGEF12 ARFGEF1 SLC1A2 THADA INA CELSR2 TIAM1 SETD5 PLIN3 | 1.78e-04 | 979 | 189 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | HAUS6 MAP1A MDGA2 ADGRV1 CNTLN CEP350 SMYD4 ALMS1 SIPA1L2 ANK2 LRRN1 NRCAM PCLO POR BTAF1 PRPF40A INA CELSR2 ZC3H12C LRBA DOP1A | 1.88e-04 | 983 | 189 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | SPATA7 IGSF6 REPS1 ERC1 HAVCR1 TTC7B TBC1D14 SIPA1L2 KRT7 AFF2 ARID4A PCLO ARHGEF12 DHX57 USF3 TIAM1 CKAP2L LIMCH1 LRBA PCDH7 GABBR1 | 1.93e-04 | 985 | 189 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | SLC39A6 UNC79 ARHGEF28 ANK2 NRCAM PCLO AKAP12 INA CELSR3 ZC3H12C | 2.03e-04 | 278 | 189 | 10 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR HAUS6 E2F7 ADGRV1 CNTLN SYCE2 CEP350 CEP120 ALMS1 BOD1L1 HSF2 ZWILCH AFF2 ANK2 LRRN1 NRCAM ARID4A E2F1 BTAF1 CEP192 HEATR1 PRPF40A KLK4 SETD5 RELL2 CKAP2L RAPGEF2 | 2.37e-04 | 1459 | 189 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.60e-04 | 185 | 189 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 REPS1 TTC7B SIPA1L2 AFF2 ARID4A DHX57 USF3 CKAP2L LRBA | 2.92e-04 | 291 | 189 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR HAUS6 E2F7 CNTLN SYCE2 CEP350 CEP120 ALMS1 BOD1L1 HSF2 ZWILCH ANK2 LRRN1 NRCAM ARID4A E2F1 BTAF1 CEP192 HEATR1 PRPF40A SETD5 RELL2 CKAP2L RAPGEF2 | 3.45e-04 | 1257 | 189 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | TPR BIRC6 CEP350 ALMS1 BOD1L1 ARID4A ARHGEF12 PRPF40A ARHGAP6 ZNF41 VPS13B CDH17 | 4.03e-11 | 186 | 195 | 12 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MDGA2 ADGRV1 FAT1 UNC79 CNTN1 NRCAM KALRN PCLO UNC13C ROS1 | 6.01e-10 | 184 | 195 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MDGA2 ADGRV1 FAT1 UNC79 CNTN1 NRCAM KALRN PCLO UNC13C ROS1 | 6.01e-10 | 184 | 195 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MDGA2 ADGRV1 FAT1 UNC79 CNTN1 NRCAM KALRN PCLO UNC13C ROS1 | 6.01e-10 | 184 | 195 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 AFDN TRIM2 ARHGEF28 ANK2 ANK3 UNC13C LRBA CDH1 PCDH7 SORL1 | 1.17e-09 | 196 | 195 | 11 | c7136b1c83bcf907eec3b02b151fa061298b6672 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 FLNB TRIM2 ARHGEF28 ANK3 PCLO MUC16 LIMCH1 MAP3K13 CDH1 TPD52 | 1.45e-09 | 200 | 195 | 11 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | SPTBN1 PLIN5 ARHGAP29 FN1 ANK2 KALRN ARID4A PCLO AKAP12 GPRC5B | 7.09e-09 | 179 | 195 | 10 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ADGRV1 PTCHD1 FAT1 KRT7 TRIM2 ANK3 ARHGEF12 UNC13C LIMCH1 CDH1 | 9.23e-09 | 184 | 195 | 10 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | ADGRV1 ANK3 PCLO CCDC141 MICAL2 ROS1 LIMCH1 MAP3K13 SLC5A8 CDH1 | 1.32e-08 | 191 | 195 | 10 | 276455a64c2c3503d5048615762eb2ee37f0ac70 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-08 | 198 | 195 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.56e-08 | 167 | 195 | 9 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.85e-08 | 168 | 195 | 9 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.22e-07 | 183 | 195 | 9 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.28e-07 | 184 | 195 | 9 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.34e-07 | 185 | 195 | 9 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-07 | 185 | 195 | 9 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.46e-07 | 187 | 195 | 9 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.53e-07 | 188 | 195 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.53e-07 | 188 | 195 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.68e-07 | 190 | 195 | 9 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | SPTBN1 ARHGAP29 ANK3 ARHGEF12 CCDC141 MICAL2 ROS1 LIMCH1 CDH1 | 1.83e-07 | 192 | 195 | 9 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.91e-07 | 193 | 195 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-07 | 193 | 195 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-07 | 194 | 195 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 194 | 195 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 FAT1 ARHGAP29 AFDN ARHGEF28 ANK3 PLEKHA6 ARHGAP6 ZNF827 | 2.00e-07 | 194 | 195 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-07 | 195 | 195 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.18e-07 | 196 | 195 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-07 | 196 | 195 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.28e-07 | 197 | 195 | 9 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.28e-07 | 197 | 195 | 9 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-07 | 198 | 195 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-07 | 198 | 195 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-07 | 198 | 195 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.48e-07 | 199 | 195 | 9 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.48e-07 | 199 | 195 | 9 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.48e-07 | 199 | 195 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.48e-07 | 199 | 195 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-07 | 200 | 195 | 9 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-07 | 200 | 195 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-07 | 200 | 195 | 9 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-07 | 200 | 195 | 9 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-07 | 200 | 195 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-07 | 200 | 195 | 9 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 167 | 195 | 8 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 167 | 195 | 8 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.93e-07 | 168 | 195 | 8 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 8.67e-07 | 170 | 195 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.47e-07 | 172 | 195 | 8 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-06 | 178 | 195 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.33e-06 | 180 | 195 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-06 | 128 | 195 | 7 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 185 | 195 | 8 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 185 | 195 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-06 | 186 | 195 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.70e-06 | 186 | 195 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 187 | 195 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.84e-06 | 188 | 195 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.84e-06 | 188 | 195 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.84e-06 | 188 | 195 | 8 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 189 | 195 | 8 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-06 | 189 | 195 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 189 | 195 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.92e-06 | 189 | 195 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-06 | 189 | 195 | 8 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 190 | 195 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.00e-06 | 190 | 195 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-06 | 191 | 195 | 8 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 191 | 195 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.08e-06 | 191 | 195 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.16e-06 | 192 | 195 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.16e-06 | 192 | 195 | 8 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.16e-06 | 192 | 195 | 8 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 192 | 195 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 193 | 195 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | fa8bcf2a5ab7b08fae98a1466a936995142b4309 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 193 | 195 | 8 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 194 | 195 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 194 | 195 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-06 | 194 | 195 | 8 | ea5b7727ffef6cb454c501979a51bc1d4108d0e4 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 194 | 195 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 195 | 195 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 196 | 195 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-06 | 198 | 195 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.82e-06 | 199 | 195 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 199 | 195 | 8 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 199 | 195 | 8 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 199 | 195 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 2.82e-06 | 199 | 195 | 8 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-06 | 199 | 195 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 2.82e-06 | 199 | 195 | 8 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-06 | 199 | 195 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-06 | 199 | 195 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.82e-06 | 199 | 195 | 8 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.92e-06 | 200 | 195 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-06 | 200 | 195 | 8 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.92e-06 | 200 | 195 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-06 | 200 | 195 | 8 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-06 | 200 | 195 | 8 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.92e-06 | 200 | 195 | 8 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | TPR NRIP1 ZBTB38 ZNF148 WNK1 CEP350 PCLO PRPF40A RAPGEF2 PCBP2 SON | 3.17e-07 | 178 | 190 | 11 | 3998_DN |
| Drug | Mitomycin | MAGEA3 MAGEA6 NRIP1 MAGEA12 FAT1 NFIL3 TRIM2 POR GRIA3 E2F1 AKAP12 LPO CKAP2L LIMCH1 TPD52 | 1.98e-06 | 410 | 190 | 15 | ctd:D016685 |
| Drug | Thimerosal | TPR REPS1 ERC1 CDHR1 SPTBN1 ADGRV1 WNK1 TASOR2 CEP350 FSIP2 SOX7 BOD1L1 HSF2 FN1 ANK2 PCLO ARHGEF12 FASTKD2 HEATR1 PLEKHA6 LRPPRC ZC3H12C RAPGEF2 PCBP2 TPD52 SON SORL1 | 2.57e-06 | 1199 | 190 | 27 | ctd:D013849 |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A | ZNF134 METTL3 TSC22D2 USP20 ALMS1 ZBTB40 SUPT20H THNSL2 RAPGEF2 PCBP2 | 6.75e-06 | 198 | 190 | 10 | 1537_DN |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L20 USP17L19 USP17L18 SMYD4 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 KMT2D USP17L6P USP17L22 USP17L15 SON | 2.27e-22 | 69 | 197 | 17 | DOID:1682 (implicated_via_orthology) |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.35e-20 | 46 | 197 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | Malignant neoplasm of breast | NRIP1 ABCA4 TTC3 WNK1 OTOF ARHGAP29 SLC39A6 BOD1L1 FLNB FN1 ANK2 NRCAM KALRN PIGS E2F1 ZMIZ1 AKAP12 EPG5 KMT2D INA MAP3K13 LRBA CDH1 VPS13B DOP1A SORL1 | 1.51e-08 | 1074 | 197 | 26 | C0006142 |
| Disease | Colorectal Carcinoma | ABCA4 WNK1 FAT1 CNTN1 FN1 ANK2 NRCAM KALRN WRN ARFGEF1 ZMIZ1 AKAP12 TIAM1 DCHS1 CDH1 SORL1 | 2.18e-05 | 702 | 197 | 16 | C0009402 |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.31e-05 | 51 | 197 | 5 | cv:CN043650 | |
| Disease | platelet crit | ANKRD31 NRIP1 GATAD2A MAP1A NHLRC2 ADGRV1 HAVCR1 ARHGAP29 USP15 KALRN ARHGEF12 PLEKHA6 TARS2 EPG5 THADA TLN1 DCHS1 ZC3HAV1 SORL1 | 2.31e-05 | 952 | 197 | 19 | EFO_0007985 |
| Disease | autosomal recessive intellectual developmental disorder (is_implicated_in) | 4.43e-05 | 2 | 197 | 2 | DOID:0060308 (is_implicated_in) | |
| Disease | cataract 48 (implicated_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:0070354 (implicated_via_orthology) | |
| Disease | D dimer measurement | 4.61e-05 | 30 | 197 | 4 | EFO_0004507 | |
| Disease | Disorder of eye | 9.50e-05 | 212 | 197 | 8 | C0015397 | |
| Disease | Nonsyndromic genetic hearing loss | 1.59e-04 | 76 | 197 | 5 | cv:C5680182 | |
| Disease | myeloid white cell count | NRIP1 SPTBN1 CDH23 S1PR2 NHLRC2 HAVCR1 TBC1D14 HSF2 ATF7 FLNB FN1 ARHGEF12 THADA MICAL2 ZNF516 ZC3HAV1 SORL1 | 1.97e-04 | 937 | 197 | 17 | EFO_0007988 |
| Disease | reticulocyte measurement | GATAD2A S1PR2 ACTN4 TSC22D2 BIRC6 SYCE2 FAT1 NFIL3 ZBTB40 AFDN FLNB TRIM2 ARHGEF28 PIKFYVE ZNF827 MICAL2 CDH1 ZC3HAV1 | 2.64e-04 | 1053 | 197 | 18 | EFO_0010700 |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.98e-04 | 48 | 197 | 4 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.98e-04 | 48 | 197 | 4 | C1862941 | |
| Disease | aortic measurement | 3.01e-04 | 251 | 197 | 8 | EFO_0020865 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 3.49e-04 | 50 | 197 | 4 | C1862939 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 4.38e-04 | 5 | 197 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Retinal Dystrophy, Early Onset Severe | 4.38e-04 | 5 | 197 | 2 | C1858080 | |
| Disease | Hereditary hearing loss and deafness | 4.59e-04 | 146 | 197 | 6 | cv:C0236038 | |
| Disease | alkaline phosphatase measurement | MAP1A SLC26A4 SPTBN1 S1PR2 KIAA0319 ZBTB40 CLUH ATF7 TRIM2 ZMIZ1 ZNF827 UNC13C THNSL2 LRBA STKLD1 ALPK2 GABBR1 | 4.94e-04 | 1015 | 197 | 17 | EFO_0004533 |
| Disease | PR interval | SPTBN1 NHLRC2 TSC22D2 FAT1 ZBTB40 SIPA1L2 KALRN ARID4A ZMIZ1 MICAL2 PLIN3 | 5.30e-04 | 495 | 197 | 11 | EFO_0004462 |
| Disease | brain disease (implicated_via_orthology) | 6.54e-04 | 6 | 197 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | reticulocyte count | GATAD2A S1PR2 TSC22D2 BIRC6 SYCE2 FAT1 ZBTB40 FLNB TRIM2 ARHGEF28 POR FAM117B PIKFYVE THADA MICAL2 CDH1 ZC3HAV1 | 6.83e-04 | 1045 | 197 | 17 | EFO_0007986 |
| Disease | serum IgG glycosylation measurement | TOPAZ1 MDGA2 TSC22D2 TBC1D14 ARHGAP29 USP15 CNTN1 WRN USF3 LPO GPRC5B | 8.32e-04 | 523 | 197 | 11 | EFO_0005193 |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.49e-04 | 28 | 197 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Hyalinosis, Segmental Glomerular | 8.49e-04 | 28 | 197 | 3 | C0086432 | |
| Disease | hearing loss | 1.06e-03 | 67 | 197 | 4 | EFO_0004238 | |
| Disease | aspartate aminotransferase measurement | ANKRD31 ABCA4 NHLRC2 BIRC6 ARHGAP29 FLNB KALRN PELI2 GPRIN3 WDR11 ZNF827 LRBA STKLD1 ALPK2 GABBR1 | 1.16e-03 | 904 | 197 | 15 | EFO_0004736 |
| Disease | serum gamma-glutamyl transferase measurement | REPS1 MAP1A S1PR2 SOX7 CEP120 SIPA1L2 KALRN ZMIZ1 THADA CELSR2 ZNF827 TLN1 LRBA STKLD1 ALPK2 | 1.29e-03 | 914 | 197 | 15 | EFO_0004532 |
| Disease | monocyte count | NRIP1 SPTBN1 CDH23 S1PR2 ADGRV1 WNK1 TBC1D14 ATF7 FLNB AFF2 FN1 KALRN ARHGEF12 PLEKHA6 ZMIZ1 THADA TLN1 ZNF516 SORL1 | 1.42e-03 | 1320 | 197 | 19 | EFO_0005091 |
| Disease | Neoplasm Invasiveness | 1.53e-03 | 184 | 197 | 6 | C0027626 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.54e-03 | 74 | 197 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Cleft palate with cleft lip | 1.55e-03 | 9 | 197 | 2 | C0158646 | |
| Disease | macula measurement | 1.75e-03 | 189 | 197 | 6 | EFO_0008375 | |
| Disease | cortical surface area measurement | SPATA7 DCHS2 REPS1 SPTBN1 LAMC3 ACTN4 ADGRV1 CNTLN TSC22D2 CEP120 FLNB TRIM2 ANK3 ARHGEF12 FAM117B THADA INA PCBP2 PCDH7 | 1.75e-03 | 1345 | 197 | 19 | EFO_0010736 |
| Disease | apolipoprotein A 1 measurement | ZBTB38 REPS1 MAP1A NHLRC2 TSC22D2 TRIM2 ARHGEF28 ZMIZ1 CELSR2 WDR11 MTTP CDH1 CDH17 SORL1 | 1.77e-03 | 848 | 197 | 14 | EFO_0004614 |
| Disease | Focal glomerulosclerosis | 1.78e-03 | 36 | 197 | 3 | C0017668 | |
| Disease | obsolete_red blood cell distribution width | NRIP1 ZNF134 GATAD2A CDH23 WNK1 BIRC6 SYCE2 SOX7 TBC1D14 ZBTB40 AFDN POLK CLUH KALRN ARPC1A EPG5 ZNF516 STKLD1 CDH1 | 1.78e-03 | 1347 | 197 | 19 | EFO_0005192 |
| Disease | lymphocyte count | NRIP1 ZBTB38 SLC26A4 CDH23 S1PR2 NHLRC2 HAVCR1 ALMS1 TBC1D14 HSF2 FLNB FN1 KALRN ARPC1A GPRIN3 PLEKHA6 ZMIZ1 THADA TLN1 ZC3HAV1 | 1.97e-03 | 1464 | 197 | 20 | EFO_0004587 |
| Disease | intraocular pressure measurement | ABCA4 SPTBN1 TSC22D2 BOD1L1 KALRN PCLO ARHGEF12 THADA CSPG4 ZNF516 | 2.34e-03 | 509 | 197 | 10 | EFO_0004695 |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 2.34e-03 | 11 | 197 | 2 | 146110 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 2.34e-03 | 11 | 197 | 2 | cv:C0342384 | |
| Disease | valine measurement | 2.41e-03 | 40 | 197 | 3 | EFO_0009792 | |
| Disease | free cholesterol in medium LDL measurement | 2.41e-03 | 40 | 197 | 3 | EFO_0022268 | |
| Disease | waist circumference | 2.48e-03 | 429 | 197 | 9 | EFO_0004342 | |
| Disease | prostate carcinoma | NRIP1 HAUS6 ZBTB38 TASOR2 CEP350 ZWILCH ANK2 ZMIZ1 ARHGAP6 THADA SCUBE2 WDR11 ZNF827 TPD52 | 2.77e-03 | 891 | 197 | 14 | EFO_0001663 |
| Disease | volumetric bone mineral density | 2.78e-03 | 42 | 197 | 3 | EFO_0007620 | |
| Disease | heat shock protein beta-1 measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0010595 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0008141 | |
| Disease | hair colour measurement | ZBTB38 ADGRV1 PTCHD1 SIPA1L2 ZMIZ1 AKAP12 EPG5 THADA KMT2D UNC13C THNSL2 | 2.97e-03 | 615 | 197 | 11 | EFO_0007822 |
| Disease | alcohol use disorder measurement | 3.24e-03 | 214 | 197 | 6 | EFO_0009458 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.28e-03 | 91 | 197 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | nevus count, cutaneous melanoma | 3.28e-03 | 91 | 197 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | obesity (implicated_via_orthology) | 3.32e-03 | 215 | 197 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 3.38e-03 | 45 | 197 | 3 | C0220636 | |
| Disease | cortical thickness | ABCA4 GATAD2A SPTBN1 LAMC3 ACTN4 ADGRV1 TSC22D2 CEP120 USP15 CLUH FLNB ARHGEF12 THADA MALRD1 SETD5 PCDH7 | 3.39e-03 | 1113 | 197 | 16 | EFO_0004840 |
| Disease | Pneumoconiosis | 3.83e-03 | 14 | 197 | 2 | C0032273 | |
| Disease | Bagassosis | 3.83e-03 | 14 | 197 | 2 | C0004681 | |
| Disease | CD209 antigen measurement | 3.83e-03 | 14 | 197 | 2 | EFO_0008077 | |
| Disease | Salivary Gland Neoplasms | 3.83e-03 | 47 | 197 | 3 | C0036095 | |
| Disease | schizophrenia, anorexia nervosa | 4.06e-03 | 48 | 197 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | body surface area | ZBTB38 E2F7 WNK1 TIAM2 NFIL3 ACAN UNC79 ARHGEF12 ZMIZ1 SETD5 GPRC5B | 4.14e-03 | 643 | 197 | 11 | EFO_0022196 |
| Disease | hearing impairment | 4.27e-03 | 98 | 197 | 4 | C1384666 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 4.40e-03 | 15 | 197 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | infant head circumference | 4.40e-03 | 15 | 197 | 2 | EFO_0004577 | |
| Disease | N-acetylmethionine measurement | 4.40e-03 | 15 | 197 | 2 | EFO_0021427 | |
| Disease | free cholesterol in LDL measurement | 4.56e-03 | 50 | 197 | 3 | EFO_0022266 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.82e-03 | 51 | 197 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | body weight | METTL3 ZBTB38 E2F7 MDGA2 ADGRV1 TSC22D2 CEP120 NFIL3 ACAN UNC79 DMTF1 NRCAM ARHGEF12 CEP192 USF3 PCDH7 GPRC5B | 4.85e-03 | 1261 | 197 | 17 | EFO_0004338 |
| Disease | platelet component distribution width | NRIP1 NHLRC2 WNK1 HAVCR1 TBC1D14 POLK USP15 SUPT20H KALRN ZMIZ1 TNN TLN1 | 5.00e-03 | 755 | 197 | 12 | EFO_0007984 |
| Disease | focal segmental glomerulosclerosis | 5.00e-03 | 16 | 197 | 2 | EFO_0004236 | |
| Disease | phospholipids in IDL measurement | 5.09e-03 | 52 | 197 | 3 | EFO_0022164 | |
| Disease | Retinitis Pigmentosa | 5.27e-03 | 104 | 197 | 4 | C0035334 | |
| Disease | phospholipids in large LDL measurement | 5.37e-03 | 53 | 197 | 3 | EFO_0022174 | |
| Disease | erythrocyte cadmium measurement | 5.65e-03 | 17 | 197 | 2 | EFO_0007807 | |
| Disease | parental longevity | 6.20e-03 | 494 | 197 | 9 | EFO_0007796 | |
| Disease | lower face morphology measurement | 6.22e-03 | 109 | 197 | 4 | EFO_0010948 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 6.32e-03 | 18 | 197 | 2 | C0342384 | |
| Disease | refractive error | 6.50e-03 | 326 | 197 | 7 | MONDO_0004892 | |
| Disease | coronary artery disease | ANKRD31 REPS1 KIAA0319 CEP120 FN1 ARID4A ARHGEF12 AKAP12 EPG5 THADA MALRD1 CELSR2 ZNF827 RAPGEF2 GABBR1 CDH17 | 6.58e-03 | 1194 | 197 | 16 | EFO_0001645 |
| Disease | total lipids in large LDL | 6.58e-03 | 57 | 197 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 6.58e-03 | 57 | 197 | 3 | EFO_0021901 | |
| Disease | Glioblastoma Multiforme | 6.62e-03 | 111 | 197 | 4 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVSSTATTQDVIETL | 61 | P55196 | |
| ESDTVVASSIVQLFT | 1991 | Q9HCE0 | |
| FSATTTVTVNVEDVQ | 226 | Q96JP9 | |
| EDVAVESSESNSLVS | 976 | P29374 | |
| TSTKASTNVDVSSVE | 401 | Q9BXX2 | |
| SQTVSVSVSQALDAR | 2556 | Q9NR09 | |
| SEDTSDQLVLEVSVT | 511 | Q6UVK1 | |
| SSARSSIAEVQSEIE | 241 | P54284 | |
| SSEITSLAEENSQVT | 1061 | Q9NXG0 | |
| EQLSEITVLTTSVDA | 1666 | P78363 | |
| VATELNAVSAQITSS | 301 | Q96Q42 | |
| TDESAQRVTASVTVS | 871 | Q8IZF6 | |
| ATRETEDTSTVTIAT | 1001 | Q86TB3 | |
| VTESIESSELVTTCQ | 1126 | Q02952 | |
| TSSQSVVVAVDRIFT | 1116 | Q9Y6D6 | |
| TLQASSQAAAEVDVT | 241 | Q16352 | |
| VTNTAIATATVTATA | 986 | P51816 | |
| TTSREEVDEAASTLT | 46 | Q9UKT5 | |
| QFSTSSRNIIVSEDT | 5006 | Q8WXG9 | |
| GTTSTVESDILTQTD | 3756 | Q8TCU4 | |
| SRETTDTDTADQVIA | 836 | O43707 | |
| TRSNSVTTAVQADLD | 691 | O14490 | |
| VSTSVQDSSVLVQRS | 231 | Q5JWR5 | |
| RSEQEGSTLSVISAT | 266 | O43299 | |
| SVRSAAEAVATSVLT | 441 | P17544 | |
| TASASVSVTVLDVND | 591 | Q9HCU4 | |
| SDATVTTTFNILVID | 326 | Q9H251 | |
| EDSDTVTVETVNSVT | 6 | Q9Y222 | |
| IIQTVATEDITSSIS | 571 | Q9Y222 | |
| ATEDITSSISQAELT | 576 | Q9Y222 | |
| TSSISQAELTVDSDI | 581 | Q9Y222 | |
| ESSTDEEVASSLTLQ | 1426 | Q9NZN5 | |
| STVSVADASKSVQVS | 226 | Q92747 | |
| ADTTNTDTALTTLEE | 606 | Q8IUD2 | |
| DEASATVSKTETSQV | 331 | P08100 | |
| VSESDTIRSISIASQ | 126 | Q9Y5K2 | |
| TEEEIKNSVSSRSAA | 301 | Q8N1W1 | |
| IVSDDESSSALEVSV | 3501 | Q01484 | |
| TAITVSDTVAVKETS | 166 | Q8N7Z5 | |
| VASVVTSAESPASRQ | 331 | Q86YP4 | |
| VKVITVNATDADSSA | 1896 | Q14517 | |
| IQLSSTAIVDVTVTD | 2896 | Q14517 | |
| DTRTSEEINTVTETS | 5786 | Q8WXI7 | |
| VFSSVSLDAATEVSR | 6096 | Q8WXI7 | |
| NASFSTDTSIVLSEV | 6961 | Q8WXI7 | |
| ETSSAIETSAVLSEV | 7256 | Q8WXI7 | |
| TSAEILAITEVTTDT | 9206 | Q8WXI7 | |
| STTVSVTITVRDVND | 1941 | Q96JQ0 | |
| FATSVAEDQSVASLT | 841 | P78559 | |
| QEAASSSSTLVEVTL | 36 | P43357 | |
| QEAASSSSTLVEVTL | 36 | P43360 | |
| QETASSSSTLVEVTL | 36 | P43365 | |
| VDTSSTVSEAVAEEV | 6 | P16435 | |
| TLDSVSASAVLSVVA | 621 | Q92823 | |
| TELTELQSQISDTSV | 231 | P08729 | |
| TIQQTTEVFTSTLDD | 311 | Q9UBS5 | |
| SSDIDIATSELSVTV | 36 | P0C7V8 | |
| SEISTVAQEITDSVL | 1161 | Q5CZC0 | |
| DSASSENRTIVVTTI | 416 | P42263 | |
| SANETSSILVESVTR | 2481 | O75369 | |
| ATEDATTTASAVVAI | 3351 | Q9Y6V0 | |
| DAVTSAQTSDSLEAI | 361 | P55157 | |
| SSNVRTVVATVLATD | 756 | O60245 | |
| AQTTRTSAISDTVSQ | 26 | P22079 | |
| SEVSSVEHTQESSVQ | 191 | Q16649 | |
| DTISIASRTSQNTVD | 1626 | O60229 | |
| SSDIIEAVAISSNSF | 1051 | P50851 | |
| REASSAESVSQVTAK | 1091 | P48552 | |
| TVQLTSSELESTLET | 656 | P42704 | |
| QVVTSIASVADTAEE | 511 | O00410 | |
| LFVADSESSTVRTVS | 426 | Q8NBF2 | |
| ISDISIDVNISSSTV | 426 | Q7Z553 | |
| EQDSTTVAAFASSLV | 181 | Q86U44 | |
| LVDSTLVEVVTASTA | 1661 | P16112 | |
| TDRQVTITGSAASIS | 331 | Q15366 | |
| SSQTLTVTVLDVNDE | 1706 | Q6V1P9 | |
| TVTISTEEQAQLTST | 331 | O75400 | |
| FVITSVASENASTSR | 21 | Q9NZH0 | |
| QSSARAEESTAIIAV | 576 | O43182 | |
| TTVLTSVSEDSRDQF | 66 | O43283 | |
| TVLSSNATVALDDIS | 616 | Q5VYJ5 | |
| SRETKSFENVSVESV | 166 | Q52LW3 | |
| VEDLSDAAIISTSTA | 2321 | Q8NFC6 | |
| TVDSDSAASISLNVE | 506 | Q9Y2I7 | |
| FSAQTSSARTQEIIE | 2126 | Q9C0G6 | |
| VSLTVNRVTSNDSAI | 101 | O95976 | |
| LSTTTVSSVAVQAGD | 11 | Q6ZP82 | |
| VTSEEENRATDSATI | 316 | Q01094 | |
| QVDVSLASAASAVES | 521 | Q96AV8 | |
| ASDLVTTVFNEATSS | 806 | O14981 | |
| SLAQLVTTSNASEVA | 426 | Q8N960 | |
| LVATSESVTEITASS | 721 | P02751 | |
| ISTNIAETSITIDDV | 911 | Q6P158 | |
| NATSAVVSLLNETVT | 206 | P43004 | |
| AVASLSTNTEQDRVS | 551 | Q6P1L5 | |
| QTIVDNSSASADLVV | 586 | Q12860 | |
| SAAVISRAETINATV | 221 | Q5VWK5 | |
| FESSQSSVINDTVVR | 181 | Q5VT06 | |
| SVSSVVSAATDTVEK | 1751 | Q12955 | |
| VSAATDTVEKVFSTT | 1756 | Q12955 | |
| STIASAIAEASVNTD | 716 | Q8TEP8 | |
| QSVSSSDRNSVTVLE | 466 | Q7Z4H7 | |
| ASTIVSALVAAEDVS | 221 | Q9H583 | |
| LSASASVTVTVLDVN | 736 | Q9NYQ7 | |
| VSVTAVDRDANSAIS | 776 | Q9NYQ7 | |
| EVQAVASVESRSVST | 321 | Q6ZVF9 | |
| ENSFSDTTSVDIIVT | 221 | Q12864 | |
| EDTVLEVTESNTTSV | 256 | Q9NQ36 | |
| ETQETTSRQVASAFI | 26 | O95136 | |
| STTATAVITVTDTND | 356 | P12830 | |
| VDISDQETSTALAAV | 621 | Q6UXK5 | |
| ATVETTIARASVLDT | 501 | Q9UPQ0 | |
| AVRVLVTSEDSSSDT | 1161 | O94851 | |
| VSLASVTALTTNVSN | 221 | Q9HC10 | |
| RSSTAILQVSVTDTN | 261 | Q9BZA8 | |
| SVEQASTTASSEVLS | 461 | Q03933 | |
| SAFVASQEAVTSSEL | 486 | Q96S52 | |
| QISSTLADTAVAAQV | 86 | Q9BW92 | |
| NSTEETATTVVAAAS | 541 | Q86TM6 | |
| LAATEAQTTRLTATE | 146 | Q14242 | |
| TVQLSSVDATSSLQD | 101 | Q8NC24 | |
| TETSLISVLADATAT | 366 | Q9BT81 | |
| SATQAARSTDVAAVV | 2126 | Q92673 | |
| EQAVRDAATETVTTA | 1741 | Q6YHU6 | |
| TSVQVTISTAETLRD | 21 | Q8IYR2 | |
| QDQTTVRTVASATTA | 251 | Q96D71 | |
| SVTTAQVATSITEDT | 16 | O75157 | |
| NVATTDTLESTTVGT | 581 | Q15046 | |
| SDLSNIVATATQTIE | 526 | Q96NR3 | |
| TDEAQITQSTISRFA | 126 | Q9HAT8 | |
| SDVDTTSATDIQRVA | 621 | Q9NYY8 | |
| RDVSLTIENTAVSDS | 86 | Q96D42 | |
| DTVATQLSEAVDATR | 141 | O60664 | |
| DLAENFVTTATVDTS | 811 | Q9P2F8 | |
| LEQSNSDVEITTTTS | 536 | Q9C0A6 | |
| STVSSSINALAAVTV | 351 | Q8N695 | |
| SEAVTSVSVSDEAIT | 361 | Q86YJ6 | |
| ALTATASSSIREDIV | 701 | Q14191 | |
| SSVAETTSQATASEV | 196 | Q6PIF2 | |
| RNVKDSVSASEVTST | 176 | Q13433 | |
| IVTDSSSLSAEAIRQ | 1551 | Q01082 | |
| TRETAETDTTEQVVA | 826 | Q08043 | |
| SDSLVAETSITSVEE | 611 | Q8IYA6 | |
| VITAEDRQVSITAST | 241 | O75153 | |
| FDSSVASQITEALVS | 256 | Q9UKZ1 | |
| SVSNEDILDLVVTSS | 171 | Q9P2M4 | |
| VVTSSSSAIVTLEND | 181 | Q9P2M4 | |
| TADVLAVSSSVASTD | 31 | Q53QW1 | |
| DVSIEAESSSLTSVT | 1351 | Q9Y4G8 | |
| RIVSIASEESETDSS | 176 | O60296 | |
| VELSQATTALTNSTI | 601 | Q9Y2H5 | |
| IAASVSILENSSRET | 646 | Q92618 | |
| DTITASQTAIALDIS | 216 | Q9H900 | |
| TVSTNIQVSASDRFA | 1456 | Q8NB66 | |
| SVDSSIVLTAASVQS | 111 | Q13009 | |
| REFSVQSLTSVVSEE | 1676 | Q8IVF5 | |
| FVATTALSRTAVQES | 401 | O43511 | |
| NLVTDRVTENTATIS | 536 | Q9UQP3 | |
| AITTTQESESLSEEL | 441 | Q8NE28 | |
| VSSADISSSSEVISQ | 521 | P12270 | |
| ATDTILTVTENIFSS | 801 | Q9Y490 | |
| ETDQTETVSVQSSVL | 441 | Q8NEM7 | |
| DAEVTASSITSVLSQ | 351 | D6R9N7 | |
| ASTVSSVVSTAEEIF | 471 | Q9UBT6 | |
| DAEVTASSITSVLSQ | 351 | A8MUK1 | |
| DAEVTASSITSVLSQ | 351 | D6R901 | |
| SVSTASEDQIVSKAA | 911 | Q9Y4E8 | |
| TSVTSNNEIITSSED | 1041 | P53804 | |
| DAEVTAASITSVLSQ | 351 | C9JLJ4 | |
| SISDSLTDRETSVNV | 526 | Q9P0W8 | |
| DAEVTASSITSVLSQ | 351 | D6RCP7 | |
| ESSITTSSSAVQQEE | 276 | P08922 | |
| ETTREDVTSNATTNT | 1106 | Q68DE3 | |
| SNAVVDSETVENISS | 121 | Q9UBS9 | |
| VVATVALTEARDSDS | 251 | Q9Y2K6 | |
| LVSTDTEDIVSAVTS | 871 | Q17R98 | |
| SEVISNTTEDTQLTS | 606 | Q8N9V7 | |
| DAEVTASSITSVLSQ | 351 | C9JPN9 | |
| LSTNIAETSITVNDV | 686 | Q9H6S0 | |
| SIVSLQASVSFEDVT | 61 | P51814 | |
| TSVAASRVEQALSEV | 661 | Q86TV6 | |
| DAEVTASSITSVLSQ | 351 | Q0WX57 | |
| TSEVLFVVSVSEDTQ | 3891 | Q7Z7G8 | |
| LTQVEVDSSSASTTL | 1201 | Q5VWN6 | |
| LTESREVSSADNVSV | 1331 | Q5VWN6 | |
| VALVNDSLSDVTSTT | 486 | Q7Z2W4 | |
| SETVVTSAKDVVASS | 111 | Q00G26 | |
| LQDTVSSVTATADVI | 366 | Q5SVZ6 | |
| TEVSVSSTENAVSSD | 671 | Q8NAP3 | |
| SEADQTVSTINTITR | 206 | Q9C0D7 | |
| TQAAVASVIDESTTA | 501 | Q9UQR1 | |
| ASVIDESTTASILES | 506 | Q9UQR1 | |
| SVADTEVTSSISINS | 561 | Q9UQR1 | |
| DAEVTASSITSVLSQ | 351 | Q6QN14 | |
| REETVTATATSQVAQ | 121 | Q9H4A3 | |
| VAATISATETLSEEE | 61 | P55327 | |
| SNAEESSILETVTAV | 96 | Q9C040 | |
| QTVVSDTELSIVESS | 641 | Q9BZH6 | |
| DAEVTASSITSVLSQ | 351 | D6RA61 | |
| DAEVTASSITSVLSQ | 351 | C9J2P7 | |
| DAEVTAASITSVLSQ | 351 | D6RBQ6 | |
| TAELSVVSTSVISEQ | 211 | P18583 | |
| LEISVQSVVTTSELS | 651 | P18583 | |
| ESSAVTVLESSTVTV | 1361 | P18583 | |
| LAVAEQEASVTSLTS | 206 | Q6P2D8 | |
| TSDVSDSEELSSLQV | 171 | Q6P4I2 | |
| DEESSSEQSISIAVS | 21 | P52741 | |
| DAEVTASSITSVLSQ | 351 | D6RJB6 | |
| TATATATVAALQETQ | 296 | Q9ULJ6 | |
| VTSTDITVQVSDSSD | 226 | Q6PL24 | |
| ASQASSELVAVTVED | 1211 | Q9NUA8 | |
| DAEVTASSITSVLSQ | 351 | C9JJH3 | |
| DAEVTASSITSVLSQ | 351 | C9JVI0 | |
| TTITAVRTNVANLSD | 1191 | Q9P2D8 | |
| EESNALQSTVESLTS | 181 | Q15916 | |
| STASSIETLVVADID | 1331 | O14686 | |
| VTDSSRQQSTAVVTV | 601 | Q5VV43 | |
| AALTQASSSVQAATV | 1316 | Q9Y6N6 |